Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?
Julie Kreyenbuhl(University of Maryland, Baltimore), M. Valenstein, Rosalinda V. Ignacio(University of Michigan), Lisa B. Dixon(University of Maryland, Baltimore), John F. McCarthy, Sohail Soliman(University of Michigan)
Cited by 101
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
|Schizophrenia Bulletin|2009|501